How many insider trades does FilingIQ track for EXC?

FilingIQ tracks 1,023 Form 4 insider transactions for EXC (EXELON CORP), covering filings from Dec 31, 2014 onwards. 20 of those were filed in the last 90 days.

Are EXC insiders net buyers or net sellers?

Across the full Form 4 history for EXC, 1 transactions (0%) were open-market purchases and 43 (4%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does EXC insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is EXC in?

EXELON CORP (EXC) is classified in the Utilities sector, specifically Utilities - Regulated Electric, with a current market capitalisation of $49.30B.

EXC insider trading

NasdaqGS Utilities

EXELON CORP — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

1,023

Last 90 days

Buys / sells

0% / 4%

Market cap

$49.30B

About EXELON CORP

Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States. The company is involved in the purchase and regulated retail sale of electricity and natural gas; transmission and distribution of electricity; and distribution of natural gas to retail customers. It serves residential, commercial, industrial, and public authorities and electric railroads customers. Exelon Corporation was incorporated in 1999 and is headquartered in Chicago, Illinois.

Company website: www.exeloncorp.com

EXC insider activity at a glance

FilingIQ has scored 1,023 insider transactions for EXC since Dec 31, 2014. The most recent filing in our index is dated Apr 28, 2026.

Across the full history, 1 open-market purchases and 43 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on EXC insider trades is 66.1/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live EXC trades on FilingIQ Raw filings on SEC EDGAR

Other Utilities tickers with recent insider activity

PNW 171

PINNACLE WEST CAPITAL CORP

CALIFORNIA WATER SERVICE GROUP

OPAL 90

OPAL Fuels Inc.

AWR 88

AMERICAN STATES WATER CO

DUK 78

Duke Energy CORP

ORA 76

ORMAT TECHNOLOGIES, INC.

13F funds holding EXC

Perpetual Ltd

$152.09M · 1.5% of AUM

MEAG MUNICH ERGO, Kapitalanlagegesellschaft mbH

$45.48M · 2.4% of AUM

Politicians who have traded EXC

Scanlon, Mary Gay

U.S. Rep. , PA · 8 trades

Frequently asked

How many insider trades does FilingIQ track for EXC?: FilingIQ tracks 1,023 Form 4 insider transactions for EXC (EXELON CORP), covering filings from Dec 31, 2014 onwards. 20 of those were filed in the last 90 days.
Are EXC insiders net buyers or net sellers?: Across the full Form 4 history for EXC, 1 transactions (0%) were open-market purchases and 43 (4%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does EXC insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is EXC in?: EXELON CORP (EXC) is classified in the Utilities sector, specifically Utilities - Regulated Electric, with a current market capitalisation of $49.30B.

Methodology & sources

Every EXC insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.